HOME >> BIOLOGY >> NEWS
Study suggests cell-cycle triggers might be cancer drug targets

BOSTON--In an experiment that appears to refute current theory, Dana-Farber Cancer Institute scientists have found that removing three key proteins believed essential to cell division and growth had little impact on normal tissue development of a mouse embryo. These same proteins, when overly active, have been linked to cancer cell proliferation.

With one significant exception, the absence of proteins called cyclin D1, D2, and D3 seemed to have no deleterious effect on development of the tissues and organs of laboratory mouse embryos. "D-type cyclins" are molecules that sense growth signals from the cell's environment and, when appropriate, switch on cell division and growth. But when the system is faulty, the cyclins over-respond to the growth signals and can cause cancerous growth. The discovery that these proteins aren't indispensable lends encouragement to an idea that blocking overactive cyclins could halt the growth of cancer.

In the Aug. 20 issue of Cell, lead author Katarzyna Kozar, MD, and senior author Peter Sicinski, MD, PhD, report on developing the first mouse embryos to date in which all three D-type cyclins were absent or "knocked out." It had been thought that at least one cyclin was required for an embryo to be viable and its tissues to form normally. Yet the "triple-knockout" mouse embryos followed a normal course of cell division and proliferation until as late as 13.5 days, when most tissues and organs are already formed. A typical mouse pregnancy last 18 days.

(In a companion paper in Cell, researchers from Spain report similar findings involving protein kinases called CDK4 and CDK6, which are molecular partners of the D-cyclins. Embryonic mice with both CDK molecules knocked out had normal tissue development as well.)

The unexpectedly viable embryos contradict theory and previous laboratory experiments. The only abnormality in the triple knockout mice was a deficiency of blood-forming cells, causing them to be pa
'"/>

Contact: Bill Schaller
william_schaller@dfci.harvard.edu
617-632-5357
Dana-Farber Cancer Institute
19-Aug-2004


Page: 1 2 3

Related biology news :

1. Study: Emission of smog ingredients from trees is increasing rapidly
2. Study explores gene transfer to modify underlying course of Alzheimers disease
3. Study reveals why eyes in some paintings seem to follow viewers
4. Study by Israeli scientists provides insight on DNA code
5. Study reveals first genetic step necessary for prostate cancer growth
6. Study of flu patients reveals virus outsmarting key drug
7. Study in Science reveals recreational fishing takes big bite of ocean catch
8. Study narrows search for genes placing men at increased risk for prostate cancer
9. Study links high carbohydrate diet to increased breast cancer risk
10. Study explains spatial orientation differences between sexes
11. Study suggests humans can speed evolution

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/6/2020)... ... 06, 2020 , ... Sickle Cell Disease Association of America, Inc. ... improving the quality, safety, efficacy and cost of red blood cell (RBC) transfusion therapy, ... mission and meet its goals. In 2020 Hemanext will collaborate with SCDAA on its ...
(Date:5/1/2020)... SEATTLE (PRWEB) , ... April 30, 2020 , ... ... for emerging infectious diseases, announced today that it had been awarded a contract ... of the Assistant Secretary for Preparedness and Response at the U.S. Department of ...
(Date:4/30/2020)... ... April 29, 2020 , ... At the start of ... innovative solutions for a wide range of industries including pharmaceutical and biopharmaceutical manufacturing, ... into the new decade, it was clear to company leadership that they would ...
Breaking Biology News(10 mins):
(Date:5/21/2020)... REDWOOD CITY, Calif. (PRWEB) , ... May 20, ... ... to announce the addition of Simon Prakash, who will serve as the company’s ... Simon joins at a time when Exo is disrupting the medical imaging space, ...
(Date:5/15/2020)... ... May 14, 2020 , ... This new service offers clients a ... pressing questions answered quickly as the need arises. Lachman’s OnCall SMEs have extensive knowledge ... affordable rates. , Lachman OnCall™ SMEs are available normal business hours Monday through ...
(Date:5/14/2020)... YORBA LINDA, Calif. (PRWEB) , ... May 12, ... ... of life science tools for translational research, is bringing together thousands of industry ... , The scientific program highlights two plenary speakers, Carl June, MD, Director of ...
(Date:5/9/2020)... LOS ANGELES (PRWEB) , ... May 08, 2020 , ... ... week’s episode of their successful business program on Sunday, May 10, 2020 and Wednesday, ... each U.S. coast! This episode’s exclusive interviews will spotlight key executives from Techolution ...
Breaking Biology Technology:
Cached News: